Neumora Therapeutics Stock (NASDAQ: NMRA) stock price, news, charts, stock research, profile.
You can purchase shares of Neumora Therapeutics (NASDAQ:NMRA) through any online brokerage.
Other companies in Neumora Therapeutics’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS) and ANI Pharmaceuticals (NASDAQ:ANIP).
Neumora Therapeutics has a consensus price target of $22.88.
The stock price for Neumora Therapeutics (NASDAQ: NMRA) is $2.1 last updated January 2, 2025 at 7:59 PM EST.
There are no upcoming dividends for Neumora Therapeutics.
Neumora Therapeutics’s Q4 earnings are confirmed for Thursday, March 6, 2025.
There is no upcoming split for Neumora Therapeutics.
Neumora Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.